Zhengye Biotechnology Holding

ZYBT · NASDAQ

$1.49+$0.00 (+0.00%)TodayMarket open · Oct 21, 11:13 AM ET · Delayed 15 min

Prev close $1.49

About ZYBT

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.

Employees: 277
Headquarters: Jilin, Jilin
Listed: Jan 7, 2025
Sector: Health Care
Industry: Pharmaceuticals
Website: ir.jlzybio.com

Leadership

Zhengye Biotechnology Holding executives
Name	Title	Since	Age
Zhenfa Han	—	2023	72
Aiden Han	—	—	—
Songlin Song	—	—	50
Ping Wang	—	—	45
Zhongyao Liu	—	—	40
Yuhong Cheng	—	—	49
Yuyou He	—	—	63
Wei Lian	—	—	44
Wenhua Sun	—	—	58
Ping Jiang	—	—	60
Wenbing Wang	—	—	54
Jiayao Wu	—	—	46

Similar companies

Companies in the same industry as Zhengye Biotechnology Holding

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.